NIH-funded research R01 grant

Understanding how propionate metabolism affects cancer spread

Official title: Propionate metabolism and cancer

Funded at Weill Medical Coll of Cornell Univ · NIH-11055311 · Data updated 2026-11-12

This study is looking at how the way cancer cells use certain nutrients might help them become more aggressive and spread in the body, which could lead to new ways to treat cancer and help patients.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWeill Medical Coll of Cornell Univ
NIH-funded
Lab location1 site (New York, United States)
Project startApril 25, 2023
Project endMarch 31, 2028
Funding year2025
Award (this year)$634,435
NIH project number5R01CA273357-03
Project IDNIH-11055311 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with cancer, particularly those at risk of metastasis.

Less likely to help

Patients with non-metastatic cancers or those not undergoing treatment may not receive direct benefits from this research.

What this research studies

This research investigates the role of propionate metabolism in the progression of cancer, particularly how tumor cells transition to a more invasive state known as epithelial-to-mesenchymal transition (EMT). By analyzing changes in proteins, metabolites, and gene expression during this process, the study aims to uncover new mechanisms that contribute to cancer metastasis. Patients may benefit from insights gained about how metabolic changes can influence cancer behavior, potentially leading to new therapeutic strategies. The research employs advanced techniques such as proteomics and metabolomics to gather comprehensive data on cellular changes.

Why it matters

Potential benefit: If successful, this research could lead to new ways to predict and prevent cancer metastasis, improving treatment outcomes for patients.

How similar studies have gone: Other research has shown promise in understanding metabolic factors in cancer progression, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Weill Medical Coll of Cornell Univ
    New York, United States
    Active

Researchers

  • Principal investigator: Blenis, John — Weill Medical Coll of Cornell Univ
  • Study coordinator: Blenis, John

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.